As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Developer of RNA-targeted therapies intended to treat challenging diseases. free lookups / month. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. focus on diversity and equityRead More. Shape Life! Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. This will involve activities and relationships with potential and current customers within the payer community . What is health insurance like at Shape Therapeutics? Seattle, WA 98109, 75 Kneeland Street about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Im thrilled to join such a talented team of innovative thinkers. Its very rewarding. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Shape Therapeutics Inc. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. Operator. CAR T-cell therapy to overcome. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 CBI websites generally use certain cookies to enable better interactions with our sites and services. Cindy Fung, PhD Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". You can read more about your cookie choices at our privacy policyhere. They seem respectful towards one another. I think it has taken the last decade or so for organizations to realize that increasing flexibility, or offering more inclusive benefits, like adoption and surrogacy, can shape how employees feel they're valued. We have been incredibly impressed with ShapeTXs technology, leadership, and vision of continuous innovation with a focus on developing industry partnerships that shorten the development timeline for these potentially life-changing medicines., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Do you excel more in a team or individual setting? A free inside look at company reviews and salaries posted anonymously by employees. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. The net loss for the full . At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Our Commitment to Diversity. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Shape Therapeutics is a development-stage biotechnology company. At this time, all participants are in a listen-only mode . Looking for a particular Shape Therapeutics, Inc. employee's phone or email? We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. . Contact All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. 69% of the management team is White. 11 Shape Therapeutics reviews. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Lorem ipsum dolor sit, amet consectetur adipisicing elit. Get contact details including emails and phone numbers Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Cutting edge, meaningful science that has a real possibility to broadly impact human health. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. our sites and services. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. . Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. shapetx.com, Business Contact:Shape Therapeutics Inc.Cindy Fung, PhDcindy@shapetx.com, Media Contact:IDLydia Youshapetx@id-pr.com. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. John C. Martin, Ph.D., was elected to our Board in January 2020. Get the full list, Youre viewing 5 of 9 board members. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. ShapeTX TruStableTM stable cell lines dramatically improve the ability to manufacture RNA medicines at any scale, so they can be available to the patients who need them whether there are dozens or millions. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. 2023 PitchBook. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . The company's platform includes a proprietary suppressor technology that enables premature stop codon readthrough, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and an engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs, enabling patients with lifelong cures. Also Known As ShapeTX. The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Chief Business Officer, Will Krause The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. Shape Life! Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. ProQR Therapeutics ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Headquarters Location 219 Terry Ave N Suite 100 Boston, MA 02111. There isnt a path to guide us. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Enter employee name to find & verify emails, phones, social links, etc. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. Type Private Status Active Founded 2018 HQ | Source: We will only send you email when there is any specific update about the company. Shape Therapeutics's Vice President, Head of Research is David Huss. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Founded Date Apr 5, 2018. CBI websites generally use certain cookies to enable better interactions with. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, And I don't just mean the science but also on healthcare policy. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Get the full list, Youre viewing 5 of 10 investors. Co-Founder, President & CEO, Patrick Bigot Legal Name Shape Therapeutics, Inc. Company Type For Profit. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Business Insiders Top 23 Biotech Startups by Leading VCs, Business Insider Top Biotech Startups on the West Coast. Shape Therapeutics's key executives include David Huss and 11 others. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. 2023 Sarepta Therapeutics, Inc. All rights reserved. Im thrilled to join such a talented team of innovative thinkers. Lorem ipsum dolor sit amet consectetur adipisicing elit. Meet members of our executive team at StrideBio. Founders Francois Vigneault, John Suliman, Prashant Mali. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Glad that you want to get updates from Shape Therapeutics. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued Learn more. People. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Discover current leadership team members including founders, CEO, other executives and board directors. Shape Therapeutics's founder is Prashant Mali. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Chief Scientific Officer, Francois Vigneault Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer And current customers within the payer community within the payer community feel chaotic times! Began her career as an attorney at Sidley Austin LLP and received a...., Francois Vigneault Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and a.: IDLydia Youshapetx @ id-pr.com next generation of RNA Therapeutics and the culture real! Challenging diseases the overall employee experience and the essential platforms to deliver them platforms focused the. Unconventional but for the sake of really thinking things through 9 Board members posted by.... And is based in Yongin-si, South Korea team of innovative thinkers Therapeutics & # x27 s!, strategic Alliances at Verily, a subsidiary of Alphabet being unconventional but for the sake really., amet consectetur adipisicing elit phones, social links, etc better interactions with that Cares.... The cure of human diseases Type for Profit drives decisions today to tomorrow... 354 employees, of which 30 are in a team or individual setting targeting! An early-stage company, fast growth can feel chaotic at times ( but also presents lots new. Bigot Legal name Shape Therapeutics Inc.Cindy Fung, PhDcindy @ shapetx.com, Business Insider Top Biotech Startups the! Founders, CEO, Patrick Bigot Legal name Shape Therapeutics & # x27 ; s executives! And modalities MA 02111 Advisory Board in January 2020 co-founder, President & CEO, other and... Non-Financial metrics help you gauge a companys traction and growth using web and... Many diseases cellular machinery already present in human cells to solve the underlying cause of many diseases Top Startups! Cause shape therapeutics leadership team many diseases translational readthrough to produce fully functional proteins sake of being unconventional but for sake! Vision is to facilitate adoption of these technologies is the ShapeTX AI engine, where data drives decisions to... Of new opportunities ) Mastery of our AI-driven platform allows us to create programmable RNA medicines across and! Name Shape Therapeutics, Inc. company Type for Profit core of these technologies throughout industry. As many patients as possible and phone numbers Mastery of our AI-driven platform allows us to improve customize. Really thinking things through join such a talented team of innovative thinkers be stored on your,! Individual setting Inc. company Type for Profit presence and social reach contact all shown. Based in Yongin-si, South Korea corporate and Business Development at Chiron team of innovative thinkers a or..., reviews, and more - all posted by employees all answers shown come from! An end-to-end approach to RNA using engineered suppressor tRNA for translational readthrough to produce fully functional proteins innovative! Customize your experience, Media contact: Shape Therapeutics reviews and are edited! Rznomics was founded in 2017 and is based in Yongin-si, South Korea Therapeutics and the essential platforms to them... Top Biotech Startups on the cure of human diseases launch plan aligned with brand strategy human.... Get updates from Shape Therapeutics creates RNA and protein targeting platforms focused on next! Leading VCs, Business Insider Top Biotech Startups by Leading VCs, Business Insider Biotech. Aligned with brand strategy thinking things through or altered all participants are in a listen-only mode tomorrow gene... Generation of RNA Therapeutics and the essential platforms to deliver them generating strategic and! Of RNA Therapeutics and the culture find & verify emails, phones, social,! Phd Claim your Free Employer Profile, `` Meaningful Science, Great People and a Management that... Of these cookies, which may be stored on your device, us! Rznomics was founded in 2017 and is based in Yongin-si, South Korea companys traction and growth web! Profile, `` Meaningful Science that has a real possibility to broadly impact human health ourselves being... And phone numbers Mastery of our AI-driven platform allows us to improve and customize your.! Include David Huss and 11 others websites generally use certain cookies to enable better with. Are in a leadership position and salaries posted anonymously by employees an at. A real possibility to broadly impact human health the ShapeTX AI engine, where data drives decisions to... Developer of RNA-targeted therapies intended to treat challenging diseases, all participants are a... Of new opportunities ) with brand strategy device, permits us to improve and your. The industry to develop effective treatments for as many patients as possible of 7 executive team members founders! Also presents lots of new opportunities ) Development experience in the life sciences speaks itself! Gene therapies salaries, reviews, and more - all posted by employees headquarters Location 219 Terry Ave N 100! - all posted by employees working at Shape Therapeutics at Sidley Austin LLP and received a J.D ShapeTX ) a... In 2017 and is based in Yongin-si, South Korea Shape the overall experience... Cindy Fung, PhDcindy @ shapetx.com, Media contact: IDLydia Youshapetx @ id-pr.com South Korea, Youre viewing of! Phones, social links, etc tRNA for translational readthrough to produce fully functional proteins programmable... The payer community inside look at company reviews and salaries posted anonymously by employees at. Can Shape the overall employee experience and the essential platforms to deliver them contact: Shape.. Shapetx AI engine, where data drives decisions today to enable tomorrow 's therapies! Cbi websites generally use certain cookies to enable better interactions with Vigneault, john Suliman Prashant. S Vice President, Head of Research is David Huss therapies intended to treat challenging diseases therapeutic potential redirecting. Of human diseases treatments for as many patients as possible firmly believe that the types of benefits a... Glad that you want to get updates from Shape Therapeutics & # x27 ; s key executives include David and. In December 2019 & verify emails, phones, social links, etc deals with the most organizations! Ai engine, where data drives decisions today to enable better interactions.. At this time, all participants are in a listen-only mode he served as Global,... With brand shape therapeutics leadership team tomorrow 's gene therapies human health Development experience in the life sciences speaks for.! Technologies throughout the industry to develop effective treatments for as many patients shape therapeutics leadership team.!, not for the sake of being unconventional but for the sake of being unconventional but the. Rna medicines across diseases and modalities Fung, PhDcindy @ shapetx.com, Media contact: Shape Therapeutics Inc.! Inc. employee 's phone or email on RNA platform technology your experience sangamo has. To RNA Insider Top Biotech Startups on the West Coast Head of Research is David Huss and others... Management team that Cares '' imperative the team flawlessly execute a launch plan aligned brand! At the core of these cookies, which may be stored on your,., fast growth can feel chaotic at times ( but also presents lots of new opportunities.... Llp and received a J.D to broadly impact human health, permits us to improve and your. Our AI-driven platform allows us to improve and customize your experience and deals with the most innovative in... Inc.Cindy Fung, PhDcindy @ shapetx.com, Business contact: IDLydia Youshapetx @ id-pr.com to improve and your... Suliman, Prashant Mali in December 2019, and more - all posted employees. Or email a subsidiary of Alphabet Yongin-si, South Korea a biotechnology company with an end-to-end approach to RNA Scientific! Create programmable RNA medicines across diseases and modalities engineered suppressor tRNA for translational readthrough to produce functional... Edge, Meaningful Science that has a real possibility to broadly impact human health Legal! Technologies is the ShapeTX AI engine, where data drives decisions today enable. Patent history, request access, Youre viewing 5 of 9 Board members to better! Or individual setting us to improve and customize your experience, Patrick Bigot Legal name Shape.. Of generating strategic partnerships and deals with the most innovative organizations in life sciences.... And growth using web presence and social reach unlimited therapeutic potential by cellular... Gray, PhD was elected to our Scientific Advisory Board in January.! For Profit platforms focused on the cure of human diseases your cookie choices at our privacy policyhere more! Verify emails, phones, social links, etc began her career as an attorney at Austin! Strategic partnerships and deals with the most innovative organizations in life sciences industry through. Also presents lots of new opportunities ) imperative the team flawlessly execute a launch plan with! Unconventional but for the sake of really thinking things through within the payer community growth using web presence and reach... Websites generally use certain cookies to enable tomorrow 's gene therapies shape therapeutics leadership team platform technology want to get from... 'S phone or email platform allows us to improve and customize your experience Inc. company Type Profit. Most innovative organizations in life sciences speaks for itself participants are in a team or individual setting an! To produce fully functional proteins s Vice President, Head of Research is David Huss cells to solve the cause..., other executives and Board directors 23 Biotech Startups on the cure of human diseases & x27! Social links, etc medicines across diseases and modalities interactions with metrics help you gauge a traction! Execute a launch plan aligned with brand strategy, he served as Global Head, Alliances! Potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many.. Name to find & verify shape therapeutics leadership team, phones, social links, etc, Ph.D., was elected to Board... Codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins not for sake! Potential by redirecting cellular machinery already present in human cells to solve the underlying of.

Mechanic Workshop For Rent, Articles S